期刊文献+

急性缺血性卒中患者静脉溶栓后24小时血压变异与血流再灌注的相关性研究 被引量:4

Relationship between early blood pressure variability and reperfusion in acute ischemic stroke patients with intravenous thrombolysis
下载PDF
导出
摘要 目的:明确急性缺血性卒中患者静脉溶栓后24h血压变异对脑组织再灌注以及3个月后神经功能结局的影响。方法:连续收集2009年6月至2014年9月期间在浙江大学医学院附属第二医院行多模式MRI检查或CT灌注扫描,接受静脉溶栓治疗的急性缺血性卒中患者的临床、影像、溶栓后24h内动态血压监测资料,评估溶栓后24h再灌注情况及3个月改良Rankin评分。记录血压均值和变异指标,后者包括标准差(sd)、连续变异度(SV)、上升变异(sv-rise)和下降变异(sv-drop)。采用二元logistic回归分析血压变异指标对再灌注及神经功能结局的影响。结果:最终纳入188例患者,其中114例(60.6%)达到再灌注,74例(39.4%)未达到再灌注。二元logistic回归分析提示,静脉溶栓后24h内收缩压连续变异(SBPsv),尤其是上升变异(SBPsv—rise)较大者不易达到再灌注(SV:OR=0.421,95%CI:0.187—0.950,P=0.037;sv—rise:OR=0.311,95%凹:0.137~0.704,P=0.005)。同时,静脉溶栓后24hSBPsv—rise高者不易达到早期神经功能恢复(OR=0.372,95%CI:0.166~0.832,P=0.016);SBPsv、SBPsv-rise和SBPsv—drop是溶栓治疗3个月后患者神经功能不良结局的独立危险因素(SV:OR=6.381,95%a:2.132~19.096,P=0.001;SV.rise:OR=5.615.95%CI:2.152~14.654,P〈0.001;sv.drop:OR=3.009,95%CI:1.263~7.169,P=0.013)。结论:急性缺血性卒中患者早期收缩压变异越大越不利于脑组织再灌注和早期神经功能恢复,并与静脉溶栓治疗后3个月患者神经功能不良结局有关。 Objective : To investigat the impacts of blood pressure (BP) variability on reperfusion and long-term outcome in patients with acute ischemic stroke after intravenous thrombolysis (IVT). Methods: The clinical data of 188 patients with acute ischemic stroke receiving IVT in Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine from June 2009 to September 2014, including hour-to-hour BP measurements, clinical manifestations, laboratory tests and radiologic findings were retrospectively analyzed. The mean 24-h BP values, and BP variability profiles, including standard deviation (sd), average squared difference between successive measurements (sv) , average squared difference between rise and drop successive measurements (sv-rise and sv-drop ) were calculated. Reperfusion, defined as 〉 50% reduction in Tmax 〉 6 s perfusion lesion volume from baseline to follow-up scans, and clinical neurological outcome based on modified Rankin scale (mRS) at 3 months after onset were also analyzed. The favorable outcome was defined as mRS 0-1 and unfavorable outcome as mRS 2-6. The binary logistic-regression model was performed to determine the independent risk factors of reperfusion and favorable outcome, respectively. Results: Among 188 patients, 114 (60. 6%) achieved reperfusion. During the 0-to-24 h blood pressure course, only systolic blood pressure (SBP) variability parameters were negatively correlated with reperfusion (sv: OR = 0.421, 95%CI:0. 187 -0. 950, P =0.037; sv-rise: OR =0. 311, 95% CI:0. 137 - 0.704, P = 0. 005) and long-term clinical outcomes (sv: OR = 6. 381, 95% CI: 2. 132 - 19. 096, P = 0. 001 ; sv-rise : OR = 5. 615, 95% CI: 2. 152 - 14. 654, P 〈 0. 001 ; sv-drop: OR = 3. 009, 95% CI: 1. 263 - 7. 169, P = 0. 013 ). Conclusion: SBP variability during the first 24 hours after IVT is negatively associated with cerebral reperfusion and unfavorable neurological outcome in patients with acute ischemic stroke receiving IVT.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2015年第6期603-610,617,共9页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省重大科技专项计划(2013C03043-3) 国家自然科学基金(81171095,81471170)
关键词 卒中/药物疗法 急性病 脑缺血/药物疗法 组织型纤溶酶原激活物/治疗应用 血栓溶解疗法 血压 再灌注 Stroke/drug therapy Acute disease Brain ischemia/drug therapy Tissue plasminogen activator/therapeuticReperfusion Brainuse Thrombolytic therapy Blood pressure
  • 相关文献

参考文献25

  • 1LEONARDI-BEE J, BATH P M, PHILLIPS S J, et al. Blood pressure and clinical outcomes in the International Stroke Trial[J]. Stroke, 2002, 33(5):1315-1320.
  • 2CASTILLO J, LEIRA R, GARCíA M M, et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome[J]. Stroke, 2004, 35(2):520-526.
  • 3OKUMURA K, OHYA Y, MAEHARA A, et al. Effects of blood pressure levels on case fatality after acute stroke[J]. J Hypertens, 2005, 23(6):1217-1223.
  • 4VEMMOS K N, TSIVGOULIS G, SPENGOS K, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke[J]. J Intern Med, 2004, 255(2):257-265.
  • 5SANDSET E C, BATH P M, BOYSEN G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke(SCAST):a randomised, placebo-controlled, double-blind trial[J]. Lancet, 2011, 377(9767):741-750.
  • 6POTTER J F, ROBINSON T G, FORD G A, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS):a randomised, placebo-controlled, double-blind pilot trial[J]. Lancet Neurol, 2009, 8(1):48-56.
  • 7ROBINSON T G, POTTER J F, FORD G A, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study(COSSACS):a prospective, randomised, open, blinded-endpoint trial[J]. Lancet Neurol, 2010, 9(8):767-775.
  • 8MIAO C Y, XIE H H, ZHAN L S, et al. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats[J]. J Hypertens, 2006, 24(6):1125-1235.
  • 9SU D F, MIAO C Y. Blood pressure variability and organ damage[J]. Clin Exp Pharmacol Physiol, 2001, 28(9):709-715.
  • 10YONG M, KASTE M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial[J]. Stroke, 2008, 39(2):366-372.

二级参考文献45

  • 1Davis SM, Donuatn GA. Parsons MW, el al. Effecls of aheplase heyond 3 h after stroke in the Eehoplanar Imaging ThrombolyticEvaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol, 2008, 7: 299-309.
  • 2Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol, 2006, 60: 508-517.
  • 3Beaulieu C, de Crespigny A, Tong DC, et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neurol, 1999, 46: 568-578.
  • 4Warach S. Thrombolysis in stroke beyond three hours: targeting patients with diffusion and perfusion MRI. Ann Neurol, 2002, 51: 11-13.
  • 5Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol, 1997, 41: 581-589.
  • 6Pedraza S, Silva Y, Mendez J, et al Comparison of preperfusion and postperfusion magnetic resonance angiography in acute stroke. Stroke, 2004, 35: 2105-2110.
  • 7Larrue V, yon Kummer R, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASS II ). Stroke, 2001, 32: 438-441.
  • 8Olivot JM, Mlynash M, Thijs VN, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke, 2009, 40 : 469-475.
  • 9Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke, 1999, 30: 1591-1597.
  • 10Singer OC, Humpich MC, Fiehler J, et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion- weighted magnetic resonance imaging. Ann Neurol, 2008, 63: 52-60.

共引文献43

同被引文献27

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部